Home LiteratureArticle Details
PMID: 8554938 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.

British journal of clinical pharmacology ·Vol. 40 ·No. 4 ·1995-10-00 ·Pages 361-7

Panserat S, Mura C, Gérard N, Vincent-Viry M, Galteau MM, Jacoz-Aigrain E, Krishnamoorthy R

Abstract

1. The study of the CYP2D genotype and phenotype of a Caucasian family revealed that a XbaI-9 kb allele was associated with the poor metabolizer phenotype. 2. A Polymerase Chain Reaction (PCR)-based assay showed that the previously described mutations D6A and D6B are not associated with the XbaI-9 kb allele. 3. To explore the molecular basis of the poor metabolizer phenotype associated with the XbaI-9 kb allele, complete sequencing of the nine exons and intron-exon boundaries of the CYP2D6 gene was undertaken after amplification by PCR. 4. All the exons were successfully amplified using CYP2D6 gene-specific primers except exon 1 which required a combination of CYP2D7 gene-specific 5' primer and a CYP2D6 gene-specific 3' primer. 5. Sequence data derived from this amplified product revealed that the XbaI-9 kb allele corresponds to a novel rearrangement of the locus. This involved a deletion of an approximately 20 kilobase (kb) DNA segment generating a hybrid 5' CYP2D7/CYP2D6 3' gene. 6. The chimeric gene is non-functional presumably due to an insertion in exon 1 (characteristic of the exon 1 of the CYP2D7 gene) which causes a shift in the reading frame with premature termination of translation.

MeSH Terms
Base Sequence Cytochrome P-450 CYP2D6 Cytochrome P-450 Enzyme System/genetics DNA Primers Female Genotype Humans Male Mixed Function Oxygenases/genetics Molecular Sequence Data Multigene Family Pedigree Phenotype Polymerase Chain Reaction Recombinant Fusion Proteins/genetics Whites/genetics
Chemicals
DNA Primers Recombinant Fusion Proteins Cytochrome P-450 Enzyme System Mixed Function Oxygenases Cytochrome P-450 CYP2D6
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Panserat S
INSERM U120, Hôpital Robert Debré, Paris, France.
Mura C
Gérard N
Vincent-Viry M
Galteau M M
Jacoz-Aigrain E
Krishnamoorthy R
References (22)
22 references, click to expand
  1. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations.
    Eur J Clin Pharmacol. 1990;39(6):533-7 PMID: 2151318
  2. NcoI RFLP in the pseudogene (CYP2D8P) of the human debrisoquine 4-hydroxylase locus.
    Nucleic Acids Res. 1991 Mar 11;19(5):1162 PMID: 1673559
  3. Molecular heterogeneity of the XbaI defined 44kb allele of the CYP2D locus within the Caucasian population.
    Br J Clin Pharmacol. 1993 Feb;35(2):161-5 PMID: 8095148
  4. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis.
    Genomics. 1993 Feb;15(2):430-2 PMID: 8449513
  5. Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes.
    Pharmacogenetics. 1991 Oct;1(1):33-41 PMID: 1688241
  6. DNA haplotype dependency of debrisoquine 4-hydroxylase (CYP2D6) expression among extensive metabolisers.
    Hum Genet. 1993 Oct;92(4):367-72 PMID: 7901140
  7. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers.
    Hum Genet. 1994 Oct;94(4):401-6 PMID: 7927337
  8. Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.
    Hum Mol Genet. 1994 Jun;3(6):923-6 PMID: 7951238
  9. A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine.
    Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):434-9 PMID: 7845481
  10. Polymorphic hydroxylation of Debrisoquine in man.
    Lancet. 1977 Sep 17;2(8038):584-6 PMID: 71400
  11. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  12. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.
    Eur J Clin Pharmacol. 1979 Sep;16(3):183-7 PMID: 499318
  13. A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
    J Med Genet. 1980 Apr;17(2):102-5 PMID: 7381862
  14. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.
    Nature. 1988 Feb 4;331(6155):442-6 PMID: 3123997
  15. Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5240-3 PMID: 2899325
  16. Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22.
    Genomics. 1988 Feb;2(2):174-9 PMID: 3410476
  17. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
    Am J Hum Genet. 1989 Dec;45(6):889-904 PMID: 2574001
  18. Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.
    J Biol Chem. 1990 Oct 5;265(28):17209-14 PMID: 2211621
  19. Identification of the primary gene defect at the cytochrome P450 CYP2D locus.
    Nature. 1990 Oct 25;347(6295):773-6 PMID: 1978251
  20. The human CYP2D locus associated with a common genetic defect in drug oxidation: a G1934----A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.
    Am J Hum Genet. 1990 Dec;47(6):994-1001 PMID: 1978565
  21. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism.
    Am J Hum Genet. 1991 May;48(5):943-50 PMID: 1673290
  22. Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6.
    Genomics. 1992 Sep;14(1):49-58 PMID: 1358797
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1995-10-00
Pages
361-7
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1365155
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com